ASIC doing more to protect retail investors
When COVID-19 hit Australia earlier this year, I don’t think any of us really knew the full extent of what would unfold in 2020.
The country went into lockdown, the stock market crashed and retail investors found themselves with more free time resulting in many turning to the stock market to make money.
In May, ASIC released a report about investor trading during the March volatility and the results were alarming, especially around leveraged trading.
Two weeks ago, ASIC released a product intervention order (20-254MR) to strengthen consumer protections around trading in contracts for difference (CFD).
This order is well overdue and in my opinion a step in the right direction.
While CFD providers have disclosed the risks of trading leveraged products, the reality is that either most retail traders don’t read the disclosures or they ignore them.
As a consequence, many retail traders lose large sums of money due to the leveraged nature of these products. While the ASIC order seeks to limit the amount of leverage a retail trader can take on, it will not stop retail traders from losing money, it will only limit it somewhat, as the majority are not highly educated or experienced in trading the stock market, let alone trading a leveraged product.
That said, I applaud ASIC for its initiatives and encourage it to do more in order to protect retail investors.
Other areas that need ASIC’s attention include high-frequency trading and algorithmic trading that increases the volatility in the market, which is detrimental to retail investors.
Dale Gillham is Chief Analyst at Wealth Within and international bestselling author of How to Beat the Managed Funds by 20%. He is also the author of the award-winning book Accelerate Your Wealth—It’s Your Money, Your Choice, which is available in all good bookstores and online at www.wealthwithin.com.au
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.